ClinicalTrials.gg

Program

PEG-rhGH with new preparation (T)

Also written as “PEG-rhGH with new preparation”.

Its studies are led by Changchun GeneScience Pharmaceutical.

Furthest: phase 1, since Oct 31, 20236 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Changchun GeneScience Pharmaceutical61 open or runningphase 1since Oct 31, 2023Oct 31, 2023none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 31, 2023First studies: 2 phase 1 studies in Pediatric Growth Hormone Deficiency (PGHD)First studyNCT06135168, NCT06135155
  2. Mar 17, 2024Phase 1 study in Pediatric Growth Hormone Deficiency (PGHD)NCT06331026 · 87 enrolled · China
  3. Apr 15, 2024Phase 1 study in Pediatric Growth Hormone Deficiency (PGHD)NCT06385145 · 16 enrolled · China
  4. Jan 22, 2025Phase 1 study in Pediatric Growth Hormone Deficiency (PGHD)NCT06797505 · 87 enrolled · China
  5. Feb 16, 2025Phase 1 study in Pediatric Growth Hormone Deficiency (PGHD)NCT06840691 · 87 planned · China

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06840691Pediatric Growth Hormone Deficiency (PGHD) · China1Not yet recruitingMay 202587
NCT06797505Pediatric Growth Hormone Deficiency (PGHD) · China1CompletedApr 29, 202587
NCT06385145Pediatric Growth Hormone Deficiency (PGHD) · China1CompletedJul 5, 202416
NCT06331026Pediatric Growth Hormone Deficiency (PGHD) · China1CompletedJul 15, 202487
NCT06135168Pediatric Growth Hormone Deficiency (PGHD) · China1CompletedNov 29, 202360
NCT06135155Pediatric Growth Hormone Deficiency (PGHD) · China1CompletedDec 4, 202348

How it is read

Names in the registry

  • “PEG-rhGH with new preparation (T)”, 4 entries
  • “PEG-rhGH with new preparation”, 2 entries

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.